Filer Snapshot

ENZO BIOCHEM INC

CIK 0000316253. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

1,149

Latest filing

14 Nov 2025

Industry

Biological Products, (No Disgnostic Substances)

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Go to filings Save page

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Schedule 13D/G

SCHEDULE 13G/A filed on 14 Nov 2025 for CIK 0000316253.

View Source Filing
Identity
Industry
Biological Products, (No Disgnostic Substances) (Office Of Life Sciences)
Business address
60 Executive Blvd, Farmingdale, NY, 11735
SEC record
State of incorporation
NY
Fiscal year end
31 July

Filer intelligence

What SEC filings say about ENZO BIOCHEM INC

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

SEC source mix

Counts show available parsed rows, not one combined ownership total.

No XML rows yet
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

No parsed ownership summary yet

We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.

Latest update

What changed recently for ENZO BIOCHEM INC

New fact period available

Latest financial period: Q1 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

16 Jun 2025

Page type

Company facts

Latest period

Q1 2025

SEC-backed company facts were refreshed from filings filed on 16 Jun 2025.

Open company facts Browse recent public updates

Benchmark Context

Benchmark context for this company

ENZO BIOCHEM INC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q1 2025. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 16 Jun 2025.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

SEC filing record

CIK 0000316253 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
1,149
First seen
20 Mar 1995
Latest filing
14 Nov 2025
Entity
Company

Observed form types

SCHEDULE 13G/A EFFECT SCHEDULE 13D/A 15-12G S-8 POS POS AM 4 8-K DEFA14A DEFM14A +44 more

Primary evidence

Open SEC filing index ENZO BIOCHEM INC SEC filings ENZO BIOCHEM INC insider transactions ENZO BIOCHEM INC company facts

Industry context: Biological Products, (No Disgnostic Substances).

Latest Filings

Showing the latest 12 of 793 SEC filings for ENZO BIOCHEM INC.

Open full filing history
SCHEDULE 13G/A File 005-32878

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-272727

EFFECT filing

Filing date
29 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-271911

EFFECT filing

Filing date
29 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-32878

SCHEDULE 13D/A filing

Filing date
22 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
15-12G File 001-09974

FORM 15-12G

Filing date
20 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-260894

POST-EFFECTIVE AMENDMENT NO TO FORM S-8

Filing date
20 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-252159

POST-EFFECTIVE AMENDMENT NO TO FORM S-8

Filing date
20 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-236958

POST-EFFECTIVE AMENDMENT NO TO FORM S-8

Filing date
20 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-226799

POST-EFFECTIVE AMENDMENT NO TO FORM S-8

Filing date
20 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-197028

POST-EFFECTIVE AMENDMENT NO TO FORM S-8

Filing date
20 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-172127

POST-EFFECTIVE AMENDMENT NO TO FORM S-8

Filing date
20 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-123712

POST-EFFECTIVE AMENDMENT NO TO FORM S-8

Filing date
20 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .